Target intelligence / Profile preview

SS18-like protein 1 (SS18L1)

Target
SS18L1
Molecular classification
Chromatin remodeling factor, Transcription coactivator, Transcription factor, Component of neuron-specific chromatin remodeling (nBAF/BAF/SWI/SNF) complex
01

Overview

SS18-like protein 1 (SS18L1, also known as CREST) is a calcium-responsive transactivator and an essential subunit of the neuron-specific BAF (nBAF) chromatin remodeling complex, homologous to the yeast SWI/SNF complex[1][3][2]. It acts as both a transcriptional coactivator and transcription factor. SS18L1 regulates the expression of neuronal genes by modulating chromatin accessibility in response to calcium signaling, in part by recruiting CREB-binding protein and other histone acetyltransferases to gene promoters[1][3]. Functional domains include an N-terminal auto-regulatory region, a central methionine-rich protein-interaction domain, and a C-terminal glutamine-rich transactivation domain[1]. It is predominantly expressed in neuronal tissue and Schwann cells and is implicated in the regulation of neuronal differentiation, dendritic growth, Schwann cell proliferation, migration, and differentiation in response to injury[1][3]. Mutations in SS18L1 are associated with amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases[1][3]. The protein interacts with multiple components of chromatin remodeling complexes and is essential for proper nervous system development and adult neurogenesis[1][3][5][6]. No approved drugs directly target SS18L1, and no established clinical biomarkers or targeted therapeutics are currently known for this specific factor[3].

Other names
Calcium-responsive transactivatorCRESTSMARCL2nBAF chromatin remodeling complex subunitSYT homolog 1SS18L1 subunit of BAF chromatin remodeling complexKIAA0693LP2261
02

Biological functions

Chromatin organizationGene expression regulationNeuronal differentiationNeuronal growthDendritic branchingSchwann cell proliferation, migration, and differentiationCalcium-dependent transcriptional activation
03

Disease associations

Neurodegenerative disease (e.g., amyotrophic lateral sclerosis)Neurological injury/regeneration (e.g., peripheral nerve injury)Sarcoma (by homology, not direct implication)
04

Safety considerations

Potential concerns relate to broad roles in neurodevelopment and chromatin regulation (e.g., off-target effects impacting neuronal development or regeneration), but specific clinical safety data not established

Beyond the preview

Go deeper on SS18-like protein 1 (SS18L1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SS18-like protein 1 (SS18L1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call